The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cyclic Peptide Compounds Market Research Report 2025

Global Cyclic Peptide Compounds Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1954632

No of Pages : 104

Ask Your Query
Synopsis
The global Cyclic Peptide Compounds market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cyclic Peptide Compounds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cyclic Peptide Compounds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cyclic Peptide Compounds include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cyclic Peptide Compounds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclic Peptide Compounds.
The Cyclic Peptide Compounds market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cyclic Peptide Compounds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclic Peptide Compounds manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bicycle Therapeutics
Apellis Pharmaceuticals
Merck
Bachem
Novartis
Roche (Chugai Pharmabody Research)
Biopharma PEG Scientific
Pfizer
AstraZeneca
Eli Lilly
GenScript Biotech
by Type
Natural Cyclic Peptide
Synthetic Cyclic Peptide
by Application
Biopharmaceutical
Environmental Protection
Scientific Research
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Cyclic Peptide Compounds by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Cyclic Peptide Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index
1 Cyclic Peptide Compounds Market Overview
1.1 Product Definition
1.2 Cyclic Peptide Compounds by Type
1.2.1 Global Cyclic Peptide Compounds Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Natural Cyclic Peptide
1.2.3 Synthetic Cyclic Peptide
1.3 Cyclic Peptide Compounds by Application
1.3.1 Global Cyclic Peptide Compounds Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Biopharmaceutical
1.3.3 Environmental Protection
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Cyclic Peptide Compounds Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts (2019-2030)
1.4.4 Global Cyclic Peptide Compounds Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Cyclic Peptide Compounds Production Market Share by Manufacturers (2019-2024)
2.2 Global Cyclic Peptide Compounds Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Cyclic Peptide Compounds, Industry Ranking, 2022 VS 2023
2.4 Global Cyclic Peptide Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Cyclic Peptide Compounds Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Cyclic Peptide Compounds, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Cyclic Peptide Compounds, Product Offered and Application
2.8 Global Key Manufacturers of Cyclic Peptide Compounds, Date of Enter into This Industry
2.9 Cyclic Peptide Compounds Market Competitive Situation and Trends
2.9.1 Cyclic Peptide Compounds Market Concentration Rate
2.9.2 Global 5 and 10 Largest Cyclic Peptide Compounds Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Cyclic Peptide Compounds Production by Region
3.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Cyclic Peptide Compounds Production Value by Region (2019-2030)
3.2.1 Global Cyclic Peptide Compounds Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Cyclic Peptide Compounds by Region (2025-2030)
3.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Cyclic Peptide Compounds Production by Region (2019-2030)
3.4.1 Global Cyclic Peptide Compounds Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Cyclic Peptide Compounds by Region (2025-2030)
3.5 Global Cyclic Peptide Compounds Market Price Analysis by Region (2019-2024)
3.6 Global Cyclic Peptide Compounds Production and Value, Year-over-Year Growth
3.6.1 North America Cyclic Peptide Compounds Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Cyclic Peptide Compounds Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Cyclic Peptide Compounds Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Cyclic Peptide Compounds Production Value Estimates and Forecasts (2019-2030)
4 Cyclic Peptide Compounds Consumption by Region
4.1 Global Cyclic Peptide Compounds Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Cyclic Peptide Compounds Consumption by Region (2019-2030)
4.2.1 Global Cyclic Peptide Compounds Consumption by Region (2019-2030)
4.2.2 Global Cyclic Peptide Compounds Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Cyclic Peptide Compounds Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Cyclic Peptide Compounds Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Cyclic Peptide Compounds Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Cyclic Peptide Compounds Production by Type (2019-2030)
5.1.1 Global Cyclic Peptide Compounds Production by Type (2019-2024)
5.1.2 Global Cyclic Peptide Compounds Production by Type (2025-2030)
5.1.3 Global Cyclic Peptide Compounds Production Market Share by Type (2019-2030)
5.2 Global Cyclic Peptide Compounds Production Value by Type (2019-2030)
5.2.1 Global Cyclic Peptide Compounds Production Value by Type (2019-2024)
5.2.2 Global Cyclic Peptide Compounds Production Value by Type (2025-2030)
5.2.3 Global Cyclic Peptide Compounds Production Value Market Share by Type (2019-2030)
5.3 Global Cyclic Peptide Compounds Price by Type (2019-2030)
6 Segment by Application
6.1 Global Cyclic Peptide Compounds Production by Application (2019-2030)
6.1.1 Global Cyclic Peptide Compounds Production by Application (2019-2024)
6.1.2 Global Cyclic Peptide Compounds Production by Application (2025-2030)
6.1.3 Global Cyclic Peptide Compounds Production Market Share by Application (2019-2030)
6.2 Global Cyclic Peptide Compounds Production Value by Application (2019-2030)
6.2.1 Global Cyclic Peptide Compounds Production Value by Application (2019-2024)
6.2.2 Global Cyclic Peptide Compounds Production Value by Application (2025-2030)
6.2.3 Global Cyclic Peptide Compounds Production Value Market Share by Application (2019-2030)
6.3 Global Cyclic Peptide Compounds Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Bicycle Therapeutics
7.1.1 Bicycle Therapeutics Cyclic Peptide Compounds Company Information
7.1.2 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
7.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Bicycle Therapeutics Main Business and Markets Served
7.1.5 Bicycle Therapeutics Recent Developments/Updates
7.2 Apellis Pharmaceuticals
7.2.1 Apellis Pharmaceuticals Cyclic Peptide Compounds Company Information
7.2.2 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
7.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Apellis Pharmaceuticals Main Business and Markets Served
7.2.5 Apellis Pharmaceuticals Recent Developments/Updates
7.3 Merck
7.3.1 Merck Cyclic Peptide Compounds Company Information
7.3.2 Merck Cyclic Peptide Compounds Product Portfolio
7.3.3 Merck Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Merck Main Business and Markets Served
7.3.5 Merck Recent Developments/Updates
7.4 Bachem
7.4.1 Bachem Cyclic Peptide Compounds Company Information
7.4.2 Bachem Cyclic Peptide Compounds Product Portfolio
7.4.3 Bachem Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Bachem Main Business and Markets Served
7.4.5 Bachem Recent Developments/Updates
7.5 Novartis
7.5.1 Novartis Cyclic Peptide Compounds Company Information
7.5.2 Novartis Cyclic Peptide Compounds Product Portfolio
7.5.3 Novartis Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Novartis Main Business and Markets Served
7.5.5 Novartis Recent Developments/Updates
7.6 Roche (Chugai Pharmabody Research)
7.6.1 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Company Information
7.6.2 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
7.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Roche (Chugai Pharmabody Research) Main Business and Markets Served
7.6.5 Roche (Chugai Pharmabody Research) Recent Developments/Updates
7.7 Biopharma PEG Scientific
7.7.1 Biopharma PEG Scientific Cyclic Peptide Compounds Company Information
7.7.2 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
7.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Biopharma PEG Scientific Main Business and Markets Served
7.7.5 Biopharma PEG Scientific Recent Developments/Updates
7.8 Pfizer
7.8.1 Pfizer Cyclic Peptide Compounds Company Information
7.8.2 Pfizer Cyclic Peptide Compounds Product Portfolio
7.8.3 Pfizer Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Pfizer Main Business and Markets Served
7.8.5 Pfizer Recent Developments/Updates
7.9 AstraZeneca
7.9.1 AstraZeneca Cyclic Peptide Compounds Company Information
7.9.2 AstraZeneca Cyclic Peptide Compounds Product Portfolio
7.9.3 AstraZeneca Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.9.4 AstraZeneca Main Business and Markets Served
7.9.5 AstraZeneca Recent Developments/Updates
7.10 Eli Lilly
7.10.1 Eli Lilly Cyclic Peptide Compounds Company Information
7.10.2 Eli Lilly Cyclic Peptide Compounds Product Portfolio
7.10.3 Eli Lilly Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Eli Lilly Main Business and Markets Served
7.10.5 Eli Lilly Recent Developments/Updates
7.11 GenScript Biotech
7.11.1 GenScript Biotech Cyclic Peptide Compounds Company Information
7.11.2 GenScript Biotech Cyclic Peptide Compounds Product Portfolio
7.11.3 GenScript Biotech Cyclic Peptide Compounds Production, Value, Price and Gross Margin (2019-2024)
7.11.4 GenScript Biotech Main Business and Markets Served
7.11.5 GenScript Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Cyclic Peptide Compounds Industry Chain Analysis
8.2 Cyclic Peptide Compounds Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Cyclic Peptide Compounds Production Mode & Process
8.4 Cyclic Peptide Compounds Sales and Marketing
8.4.1 Cyclic Peptide Compounds Sales Channels
8.4.2 Cyclic Peptide Compounds Distributors
8.5 Cyclic Peptide Compounds Customers
9 Cyclic Peptide Compounds Market Dynamics
9.1 Cyclic Peptide Compounds Industry Trends
9.2 Cyclic Peptide Compounds Market Drivers
9.3 Cyclic Peptide Compounds Market Challenges
9.4 Cyclic Peptide Compounds Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Cyclic Peptide Compounds Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Cyclic Peptide Compounds Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Cyclic Peptide Compounds Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Cyclic Peptide Compounds Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Cyclic Peptide Compounds Production Market Share by Manufacturers (2019-2024)
Table 6. Global Cyclic Peptide Compounds Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Cyclic Peptide Compounds Production Value Share by Manufacturers (2019-2024)
Table 8. Global Key Players of Cyclic Peptide Compounds, Industry Ranking, 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Cyclic Peptide Compounds as of 2023)
Table 10. Global Market Cyclic Peptide Compounds Average Price by Manufacturers (US$/kg) & (2019-2024)
Table 11. Global Key Manufacturers of Cyclic Peptide Compounds, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Cyclic Peptide Compounds, Product Offered and Application
Table 13. Global Key Manufacturers of Cyclic Peptide Compounds, Date of Enter into This Industry
Table 14. Global Cyclic Peptide Compounds Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyclic Peptide Compounds Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cyclic Peptide Compounds Production Value (US$ Million) by Region (2019-2024)
Table 18. Global Cyclic Peptide Compounds Production Value Market Share by Region (2019-2024)
Table 19. Global Cyclic Peptide Compounds Production Value (US$ Million) Forecast by Region (2025-2030)
Table 20. Global Cyclic Peptide Compounds Production Value Market Share Forecast by Region (2025-2030)
Table 21. Global Cyclic Peptide Compounds Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Cyclic Peptide Compounds Production (Tons) by Region (2019-2024)
Table 23. Global Cyclic Peptide Compounds Production Market Share by Region (2019-2024)
Table 24. Global Cyclic Peptide Compounds Production (Tons) Forecast by Region (2025-2030)
Table 25. Global Cyclic Peptide Compounds Production Market Share Forecast by Region (2025-2030)
Table 26. Global Cyclic Peptide Compounds Market Average Price (US$/kg) by Region (2019-2024)
Table 27. Global Cyclic Peptide Compounds Market Average Price (US$/kg) by Region (2025-2030)
Table 28. Global Cyclic Peptide Compounds Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 29. Global Cyclic Peptide Compounds Consumption by Region (2019-2024) & (Tons)
Table 30. Global Cyclic Peptide Compounds Consumption Market Share by Region (2019-2024)
Table 31. Global Cyclic Peptide Compounds Forecasted Consumption by Region (2025-2030) & (Tons)
Table 32. Global Cyclic Peptide Compounds Forecasted Consumption Market Share by Region (2019-2024)
Table 33. North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 34. North America Cyclic Peptide Compounds Consumption by Country (2019-2024) & (Tons)
Table 35. North America Cyclic Peptide Compounds Consumption by Country (2025-2030) & (Tons)
Table 36. Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 37. Europe Cyclic Peptide Compounds Consumption by Country (2019-2024) & (Tons)
Table 38. Europe Cyclic Peptide Compounds Consumption by Country (2025-2030) & (Tons)
Table 39. Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 40. Asia Pacific Cyclic Peptide Compounds Consumption by Region (2019-2024) & (Tons)
Table 41. Asia Pacific Cyclic Peptide Compounds Consumption by Region (2025-2030) & (Tons)
Table 42. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 43. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2019-2024) & (Tons)
Table 44. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2025-2030) & (Tons)
Table 45. Global Cyclic Peptide Compounds Production (Tons) by Type (2019-2024)
Table 46. Global Cyclic Peptide Compounds Production (Tons) by Type (2025-2030)
Table 47. Global Cyclic Peptide Compounds Production Market Share by Type (2019-2024)
Table 48. Global Cyclic Peptide Compounds Production Market Share by Type (2025-2030)
Table 49. Global Cyclic Peptide Compounds Production Value (US$ Million) by Type (2019-2024)
Table 50. Global Cyclic Peptide Compounds Production Value (US$ Million) by Type (2025-2030)
Table 51. Global Cyclic Peptide Compounds Production Value Market Share by Type (2019-2024)
Table 52. Global Cyclic Peptide Compounds Production Value Market Share by Type (2025-2030)
Table 53. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2019-2024)
Table 54. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2025-2030)
Table 55. Global Cyclic Peptide Compounds Production (Tons) by Application (2019-2024)
Table 56. Global Cyclic Peptide Compounds Production (Tons) by Application (2025-2030)
Table 57. Global Cyclic Peptide Compounds Production Market Share by Application (2019-2024)
Table 58. Global Cyclic Peptide Compounds Production Market Share by Application (2025-2030)
Table 59. Global Cyclic Peptide Compounds Production Value (US$ Million) by Application (2019-2024)
Table 60. Global Cyclic Peptide Compounds Production Value (US$ Million) by Application (2025-2030)
Table 61. Global Cyclic Peptide Compounds Production Value Market Share by Application (2019-2024)
Table 62. Global Cyclic Peptide Compounds Production Value Market Share by Application (2025-2030)
Table 63. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2019-2024)
Table 64. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2025-2030)
Table 65. Bicycle Therapeutics Cyclic Peptide Compounds Company Information
Table 66. Bicycle Therapeutics Cyclic Peptide Compounds Specification and Application
Table 67. Bicycle Therapeutics Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 68. Bicycle Therapeutics Main Business and Markets Served
Table 69. Bicycle Therapeutics Recent Developments/Updates
Table 70. Apellis Pharmaceuticals Cyclic Peptide Compounds Company Information
Table 71. Apellis Pharmaceuticals Cyclic Peptide Compounds Specification and Application
Table 72. Apellis Pharmaceuticals Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 73. Apellis Pharmaceuticals Main Business and Markets Served
Table 74. Apellis Pharmaceuticals Recent Developments/Updates
Table 75. Merck Cyclic Peptide Compounds Company Information
Table 76. Merck Cyclic Peptide Compounds Specification and Application
Table 77. Merck Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 78. Merck Main Business and Markets Served
Table 79. Merck Recent Developments/Updates
Table 80. Bachem Cyclic Peptide Compounds Company Information
Table 81. Bachem Cyclic Peptide Compounds Specification and Application
Table 82. Bachem Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 83. Bachem Main Business and Markets Served
Table 84. Bachem Recent Developments/Updates
Table 85. Novartis Cyclic Peptide Compounds Company Information
Table 86. Novartis Cyclic Peptide Compounds Specification and Application
Table 87. Novartis Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 88. Novartis Main Business and Markets Served
Table 89. Novartis Recent Developments/Updates
Table 90. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Company Information
Table 91. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Specification and Application
Table 92. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 93. Roche (Chugai Pharmabody Research) Main Business and Markets Served
Table 94. Roche (Chugai Pharmabody Research) Recent Developments/Updates
Table 95. Biopharma PEG Scientific Cyclic Peptide Compounds Company Information
Table 96. Biopharma PEG Scientific Cyclic Peptide Compounds Specification and Application
Table 97. Biopharma PEG Scientific Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 98. Biopharma PEG Scientific Main Business and Markets Served
Table 99. Biopharma PEG Scientific Recent Developments/Updates
Table 100. Pfizer Cyclic Peptide Compounds Company Information
Table 101. Pfizer Cyclic Peptide Compounds Specification and Application
Table 102. Pfizer Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 103. Pfizer Main Business and Markets Served
Table 104. Pfizer Recent Developments/Updates
Table 105. AstraZeneca Cyclic Peptide Compounds Company Information
Table 106. AstraZeneca Cyclic Peptide Compounds Specification and Application
Table 107. AstraZeneca Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 108. AstraZeneca Main Business and Markets Served
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Eli Lilly Cyclic Peptide Compounds Company Information
Table 111. Eli Lilly Cyclic Peptide Compounds Specification and Application
Table 112. Eli Lilly Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 113. Eli Lilly Main Business and Markets Served
Table 114. Eli Lilly Recent Developments/Updates
Table 115. GenScript Biotech Cyclic Peptide Compounds Company Information
Table 116. GenScript Biotech Cyclic Peptide Compounds Specification and Application
Table 117. GenScript Biotech Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 118. GenScript Biotech Main Business and Markets Served
Table 119. GenScript Biotech Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Cyclic Peptide Compounds Distributors List
Table 123. Cyclic Peptide Compounds Customers List
Table 124. Cyclic Peptide Compounds Market Trends
Table 125. Cyclic Peptide Compounds Market Drivers
Table 126. Cyclic Peptide Compounds Market Challenges
Table 127. Cyclic Peptide Compounds Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Product Picture of Cyclic Peptide Compounds
Figure 2. Global Cyclic Peptide Compounds Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Cyclic Peptide Compounds Market Share by Type: 2023 VS 2030
Figure 4. Natural Cyclic Peptide Product Picture
Figure 5. Synthetic Cyclic Peptide Product Picture
Figure 6. Global Cyclic Peptide Compounds Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Cyclic Peptide Compounds Market Share by Application: 2023 VS 2030
Figure 8. Biopharmaceutical
Figure 9. Environmental Protection
Figure 10. Scientific Research
Figure 11. Others
Figure 12. Global Cyclic Peptide Compounds Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cyclic Peptide Compounds Production Value (US$ Million) & (2019-2030)
Figure 14. Global Cyclic Peptide Compounds Production Capacity (Tons) & (2019-2030)
Figure 15. Global Cyclic Peptide Compounds Production (Tons) & (2019-2030)
Figure 16. Global Cyclic Peptide Compounds Average Price (US$/kg) & (2019-2030)
Figure 17. Cyclic Peptide Compounds Report Years Considered
Figure 18. Cyclic Peptide Compounds Production Share by Manufacturers in 2023
Figure 19. Cyclic Peptide Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. The Global 5 and 10 Largest Players: Market Share by Cyclic Peptide Compounds Revenue in 2023
Figure 21. Global Cyclic Peptide Compounds Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Cyclic Peptide Compounds Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. Global Cyclic Peptide Compounds Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 24. Global Cyclic Peptide Compounds Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. North America Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Europe Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. China Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Japan Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Cyclic Peptide Compounds Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 30. Global Cyclic Peptide Compounds Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 32. North America Cyclic Peptide Compounds Consumption Market Share by Country (2019-2030)
Figure 33. U.S. Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 34. Canada Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 35. Europe Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 36. Europe Cyclic Peptide Compounds Consumption Market Share by Country (2019-2030)
Figure 37. Germany Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 38. France Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 39. U.K. Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 40. Italy Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 41. Russia Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 42. Asia Pacific Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 43. Asia Pacific Cyclic Peptide Compounds Consumption Market Share by Region (2025-2030)
Figure 44. China Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 45. Japan Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 46. South Korea Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 47. China Taiwan Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 48. Southeast Asia Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 49. India Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 50. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 51. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 53. Brazil Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 54. Turkey Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 55. GCC Countries Cyclic Peptide Compounds Consumption and Growth Rate (2019-2030) & (Tons)
Figure 56. Global Production Market Share of Cyclic Peptide Compounds by Type (2019-2030)
Figure 57. Global Production Value Market Share of Cyclic Peptide Compounds by Type (2019-2030)
Figure 58. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2019-2030)
Figure 59. Global Production Market Share of Cyclic Peptide Compounds by Application (2019-2030)
Figure 60. Global Production Value Market Share of Cyclic Peptide Compounds by Application (2019-2030)
Figure 61. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2019-2030)
Figure 62. Cyclic Peptide Compounds Value Chain
Figure 63. Cyclic Peptide Compounds Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock